Laxbene Junior Für Kinder Von 6 Monaten Bis 8 Jahre

Macrogol 4000, the active ingredient in Laxbene Junior Für Kinder Von 6 Monaten Bis 8 Jahre, is an osmotic laxative presented as an oral solution for oral use. It treats constipation in children from 6 months to 8 years by retaining water in the intestinal lumen and softening stool. GNH USA supplies Laxbene Junior Für Kinder Von 6 Monaten Bis 8 Jahre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Laxbene Junior is an osmotic laxative indicated for the management of constipation in the pediatric population. - Constipation in infants (6 months – 2 years): softens stool and promotes regular bowel movements. - Constipation in toddlers (2 – 5 years): reduces stool hardness and eases passage. - Constipation in early school‑age children (5 – 8 years): facilitates natural defecation patterns and prevents fecal retention.

The most frequently reported reactions are mild and transient.

Common Side Effects: - Abdominal bloating - Flatulence - Mild diarrhea - Nausea - Stomach cramps - Increased stool frequency

Serious or Rare Side Effects: - Severe abdominal pain - Allergic reactions such as rash, swelling or urticaria - Electrolyte imbalance (e.g., low sodium or potassium) - Severe dehydration - Intestinal obstruction - Persistent vomiting

Use of Laxbene Junior requires careful consideration of patient‑specific factors. - Dose adjustment: follow the prescriber's recommendation, especially in children with renal impairment. - Fluid intake: ensure adequate hydration to support the osmotic effect. - Monitor for dehydration: watch for signs of excessive fluid loss, particularly in very young children. - Hypersensitivity: avoid in patients with known allergy to macrogol or polyethylene glycol. - Bowel obstruction: do not use if a mechanical obstruction is suspected. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Macrogol 4000 may interact with other medications that affect fluid balance or gastrointestinal motility.

Major Interactions (Avoid): - Concomitant use with other osmotic laxatives (risk of excessive fluid loss). - Combination with stimulant laxatives (potential electrolyte disturbances). - Co‑administration with potent diuretics (may exacerbate dehydration).

Moderate Interactions (Monitor Closely): - Antacids (possible alteration of macrogol’s efficacy). - Oral rehydration solutions (may affect fluid balance). - Certain antibiotics such as tetracyclines (reduced absorption when taken together).